The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Laktionov K.K.

N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia

Breder V.V.

N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia

Bolotina L.V.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of Ministry of Russia

Vladimirova L.Yu.

National Medical Research Center for Oncology of the Ministry of Health of Russia

Gordiev M.G.

OOO «NATIONAL BIOSERVICE»

Demidova I.A.

Moscow City Oncology Hospital No. 62

Moiseenko F.V.

Saint Petersburg Clinical Research and Practice Center of Specialized Medical Care in Oncology

Orlov S.V.

Acad. I.P. Pavlov First Saint Petersburg State Medical University of the Ministry of Health of Russia

Reutova E.V.

N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia

Savelov N.A.

Moscow City Oncology Hospital No. 62

Sakaeva D.D.

Bashkir State Medical University

Smolin A.V.

Acad. N.N. Burdenko Main Military Clinical Hospital of the Ministry of Defense of Russia

ALK-, ROS1-, RET-, and NTRK-positive non-small cell lung cancer: diagnosis and targeted therapy. Resolution of the Expert Panel

Authors:

Laktionov K.K., Breder V.V., Bolotina L.V., Vladimirova L.Yu., Gordiev M.G., Demidova I.A., Moiseenko F.V., Orlov S.V., Reutova E.V., Savelov N.A., Sakaeva D.D., Smolin A.V.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2021;10(4): 41‑43

Views: 1476

Downloaded: 53


To cite this article:

Laktionov KK, Breder VV, Bolotina LV, et al. . ALK-, ROS1-, RET-, and NTRK-positive non-small cell lung cancer: diagnosis and targeted therapy. Resolution of the Expert Panel. P.A. Herzen Journal of Oncology. 2021;10(4):41‑43. (In Russ.)
https://doi.org/10.17116/onkolog20211004141

Recommended articles:
Mole­cularly targeted therapy for biliary cancer. P.A. Herzen Journal of Onco­logy. 2024;(3):34-39

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.